# CONSTELLATION PHARMACEUTICALS INC

CONSTELLATION PHARMACEUTICALS INC is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** CONSTELLATION PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001434418

## About

CONSTELLATION PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001434418, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-02-24, it reported net income of USD -126,357,000; total assets of USD 441,854,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Net income:** -$126.4M (USD -126,357,000)
- **Total assets:** $441.9M (USD 441,854,000)
- **Cash and equivalents:** $163.7M (USD 163,693,000)
- **Operating cash flow:** -$111.4M (USD -111,424,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Net income:** -$85.5M (USD -85,550,000)
- **Total assets:** $399.1M (USD 399,130,000)
- **Cash and equivalents:** $334.3M (USD 334,332,000)
- **Operating cash flow:** -$72.2M (USD -72,248,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$59.9M (USD -59,925,000)
- **Total assets:** $118.9M (USD 118,938,000)
- **Cash and equivalents:** $114.6M (USD 114,592,000)
- **Operating cash flow:** -$48.8M (USD -48,823,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2021-07-15 — period 2021-07-15 — 8-K
- Form 8-K — filed 2021-06-02 — period 2021-06-02 — 8-K
- Form 8-K — filed 2021-06-02 — period 2021-06-02 — 8-K
- Form 10-Q — filed 2021-05-10 — period 2021-03-31 — 10-Q
- Form DEF 14A — filed 2021-04-23 — period 2021-06-02 — DEF 14A
- Form 10-K — filed 2021-02-24 — period 2020-12-31 — 10-K
- Form SC 13G — filed 2021-02-04 — SEC SCHEDULE 13G
- Form SC 13G — filed 2021-02-02
- Form SC 13G — filed 2021-02-01 — SC 13G
- Form 8-K — filed 2020-12-07 — period 2020-12-07 — 8-K
- Form 8-K — filed 2020-11-18 — period 2020-11-13 — 8-K
- Form 8-K — filed 2020-11-09 — period 2020-11-03 — 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/constellation-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology